Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 460 results for "Cgix"

Cancer Genetics wins second patent for FHACT test to improve c...

Cancer diagnostics company Cancer Genetics (NasdaqCM:CGIX) disclosed on Tuesday the receipt of the second US patent (US Patent No. 8,883,414) for its proprietary FISH-based HPV-Associated Cancer Test (FHACT) for cervical cancer detection in ... Individual.com, 1 week ago

Cancer Genetics, Inc. Recognized in Deloitte's 2014 Technology Fast 500(TM) Awards

RUTHERFORD, N.J., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc . (Nasdaq:CGIX) ("CGI" or "the company"), an emerging leader in DNA-based cancer diagnostics, today announced it ranked 303 on Deloitte's Technology Fast 500, a ranking of the ...
 CNN Money5 days ago Cancer Genetics Inc to Present at Canaccord Genuity Medical Technology & Diagnostics Conference  Morningstar.com1 week ago Cancer Genetics Inc to Present on Company's Targeted Next-Generation Sequencing Panels at AMP  PredictWallStreet1 week ago Cancer Genetics Announces Strong Third Quarter With Growth Across All Categories  Digital Producer1 week ago
[x]  
Securities Technology Monitor

RedChip Issues Research Note on Cancer Genetics

RedChip Companies, Inc., today announced it has issued a research note on Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers. To receive ...
 Individual.com1 week ago RedChip Announces Presentation Schedule for Its October 15-16 Online Investor Conference  RCL Advisors1 month ago
[x]  

Cancer Genetics Sets New 12-Month Low at $5.76 (CGIX)

Cancer Genetics (NASDAQ:CGIX)'s share price reached a new 52-week low during trading on Wednesday , Analyst RN reports. The company traded as low as $5.76 and last traded at $5.84, with a volume of 38,467 shares traded. The stock had previously ...
 American Banking News2 days ago Cancer Genetics Reaches New 1-Year Low at $7.87 (CGIX)  American Banking News1 month ago Cancer Genetics Hits New 1-Year Low at $8.25 (CGIX)  American Banking News2 months ago

Cancer Genetics (CGIX) Releases Quarterly Earnings Results

Cancer Genetics (NASDAQ:CGIX) posted its quarterly earnings results on Monday. The company reported ($0.41) earnings per share for the quarter, beating the analysts consensus estimate of ($0.51) by $0.10, AR Network reports. On the ratings front, ...
 SleekMoney1 week ago Cancer Genetics (CGIX) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS  American Banking News1 week ago Morning Market Movers  Benzinga.com1 week ago

Cancer Genetics Inc. (CGIX) Leads Small-Cap Stars ...

Equities.com created the Small-Cap Stars , our proprietary list of small-cap companies best-positioned for future success, to help investors identify those small-cap companies with the most fundamental strength and the best chance for future ...
 Equities.com1 week ago Leading Small-Cap Stars Health Care Stock for November 10 Morning Session is Cancer Genetics Inc. (CGIX)  Equities.com1 week ago

Cancer Genetics (CGIX) Attains Another U.S. Patent Covering FHACT for Cervical Cancer

Visit StreetInsider.com at http://www.streetinsider.com/news.php-st=p&id=9998369 for the
 Town Hall1 week ago Cancer Genetics (CGIX), Columbia's Azra Raza Enter Research Collaboration  Town Hall1 month ago
[x]  

Cancer Genetics Sets New 1-Year Low at $6.00 (CGIX)

Cancer Genetics (NASDAQ:CGIX) hit a new 52-week low during trading on Friday , StockRatingsNetwork.com reports. The company traded as low as $6.00 and last traded at $6.00, with a volume of 108,379 shares traded. The stock had previously closed at ...
 Ticker Report2 weeks ago

Novartis Reports Nine New Analyses Show Co.'s LCZ696; Trevena Announces Positive Top-Line Results From Phase 2a/b Study Of TRV130

Below is a look at some of the headlines for companies that made news in the healthcare sector on November 17, 2014. New data on Novartis` investigational medicine, LCZ696, for patients with heart failure with reduced ejection fraction (HFrEF) ...
 BioMedReports4 days ago Chimerix's Brincidofovir Selected for Use in Ebola Clinical Trial; AstraZeneca and Isis Pharma to Co-Develop Targeted Oligonucleotide Delivery Methods  BioMedReports1 week ago Biocept Launches Lung Cancer Offering; Ocular Enrolls First Patients in Phase 2b Clinical Trial for Travoprost  BioMedReports1 week ago Immunomedics Provides Update On Phase 2 Study Of Isactuzumab Govitecan; Hemispherx Reports New Evidence of Ampligen(R)  BioMedReports3 weeks ago
[x]  

Leading Health Care Stock for Small-Cap Stars is Tg Therapeutics Inc. (TGTX) for November 10

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars , our proprietary list of small-cap companies with ...
 Equities.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less